Heart News and Research

RSS

Study shows promise of zilebesiran injection in reducing systolic blood pressure

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology's Annual Scientific Session.

7 Apr 2024

Behavioral economics strategies boost daily walking by 10% in high-risk cardiovascular patients

Strategies such as earning points or small amounts of money encouraged people at high risk for heart disease or stroke to increase their daily walking by about 10% and sustain the increase for a year, according to research being presented at the American College of Cardiology's Annual Scientific Session.

7 Apr 2024

Study reveals vascular health disparities between Black and white men with prostate cancer diagnosis

Microvascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to researchers at the Medical College of Georgia.

7 Apr 2024

Acetaminophen at moderate doses may alter heart function

The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted in mice.

7 Apr 2024

NYU Langone Heart experts unveil breakthroughs at ACC 2024

Experts from NYU Langone Heart are presenting their latest clinical findings and research discoveries during the American College of Cardiology (ACC) 2024 Annual Scientific Session & Expo, held April 6 to 8 in Atlanta.

5 Apr 2024

PeriCord bioimplants show promise in heart regeneration studies

The promising results obtained in a clinical trial with a pioneering advanced therapy drug named PeriCord, which aims to repair the heart of patients who have suffered a heart attack, confirm the feasibility of new therapies based on the application of stem cells and tissue engineering to promote the regeneration of damaged tissues.

5 Apr 2024

Neuroscientists identify age-defying RNAs in the brain

Certain RNA molecules in the nerve cells in the brain last a life time without being renewed. Neuroscientists from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now demonstrated that this is the case together with researchers from Germany, Austria and the USA.

5 Apr 2024

Lifetime stress exposure impacts cardiovascular reactivity in Black Americans, study shows

Daily and lifetime exposure to stress may cause wear and tear on the stress responses of Black Americans, blunting their biological stress response, a new University of Michigan study shows.

5 Apr 2024

New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy

A machine learning-based heart disease prediction model (ML-HDPM) that uses various combinations of information and numerous recognized categorization methods.

5 Apr 2024

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases.

5 Apr 2024

Dietary choices are linked to higher rates of preeclampsia among Latinas

For pregnant Latinas, food choices could reduce the risk of preeclampsia, a dangerous type of high blood pressure, and a diet based on cultural food preferences, rather than on U.S. government benchmarks, is more likely to help ward off the illness, a new study shows.

5 Apr 2024

Hypertension linked to higher dementia risk in middle-aged patients

Study investigates the relationship between hypertension in middle-aged individuals and the increased risk of developing dementia, utilizing the CAIDE score for dementia risk prediction in a cohort of white Argentinian hypertensive patients.

4 Apr 2024

Unlocking the secrets of long-lived RNAs in brain cells

After two decades in the United States, Martin Hetzer returned home to Austria in 2023 to become the 2nd President of the Institute of Science and Technology Austria (ISTA).

4 Apr 2024

Mayo Clinic research shows health benefits of active workstations

A recent Mayo Clinic study suggests that active workstations incorporating a walking pad, bike, stepper and/or standing desk are successful strategies for reducing sedentary time and improving mental cognition at work without reducing job performance.

4 Apr 2024

BMI influences efficacy of nerve-stimulation treatment for sleep apnea, study finds

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up to 40, a weight range generally described as severely obese.

4 Apr 2024

Interferon-beta deficiency alters brain response in neuroHIV mouse model

NeuroHIV refers to the effects of HIV infection on the brain or central nervous system and, to some extent, the spinal cord and peripheral nervous system.

4 Apr 2024

Anti-inflammatory therapy shows promise to treat patients following acute myocardial infarction

Research into the protective effects of two anti-inflammatory molecules, transforming growth factor-beta1 (TGFβ1) and Heligmosomoides polygyrus TGM (HpTGM), following heart attack found that both proteins reduced the inflammatory response within the injured heart and reduced mature scarring.

4 Apr 2024

The horrors of TMJ: Chronic pain, metal jaws, and futile treatments

A TMJ patient in Maine had six surgeries to replace part or all of the joints of her jaw.

4 Apr 2024

Rethinking exercise in post-COVID care

People suffering from post-COVID have been discouraged from exercising because early observations suggested it could be harmful.

4 Apr 2024

Study evaluates the feasibility of discontinuing CLL specialist care

A study published today in Blood Advances showed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CLL) with no symptoms and a low risk for ever needing treatment, those who stopped seeing their doctors for specialized follow-up had fewer hospital visits, fewer infections, and similar survival after three years compared to those who continued to undergo specialized follow-up.

4 Apr 2024

Heart News and Research

Study shows promise of zilebesiran injection in reducing systolic blood pressure

Behavioral economics strategies boost daily walking by 10% in high-risk cardiovascular patients

Study reveals vascular health disparities between Black and white men with prostate cancer diagnosis

Acetaminophen at moderate doses may alter heart function

NYU Langone Heart experts unveil breakthroughs at ACC 2024

PeriCord bioimplants show promise in heart regeneration studies

Neuroscientists identify age-defying RNAs in the brain

Lifetime stress exposure impacts cardiovascular reactivity in Black Americans, study shows

New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Dietary choices are linked to higher rates of preeclampsia among Latinas

Hypertension linked to higher dementia risk in middle-aged patients

Unlocking the secrets of long-lived RNAs in brain cells

Mayo Clinic research shows health benefits of active workstations

BMI influences efficacy of nerve-stimulation treatment for sleep apnea, study finds

Interferon-beta deficiency alters brain response in neuroHIV mouse model

Anti-inflammatory therapy shows promise to treat patients following acute myocardial infarction

The horrors of TMJ: Chronic pain, metal jaws, and futile treatments

Rethinking exercise in post-COVID care

Study evaluates the feasibility of discontinuing CLL specialist care

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News